BioStem Technologies (BSEM) Revenue & Revenue Breakdown
BioStem Technologies Revenue Highlights
Latest Revenue (Y)
$47.48M
Latest Revenue (Q)
$7.90M
BioStem Technologies Revenue by Period
BioStem Technologies Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $47.48M | -84.27% |
| 2024-12-31 | $301.83M | 1708.93% |
| 2023-12-31 | $16.69M | 142.69% |
| 2022-12-31 | $6.88M | 58.38% |
| 2021-12-31 | $4.34M | 72.14% |
| 2020-12-31 | $2.52M | -4.13% |
| 2019-12-31 | $2.63M | 158.59% |
| 2018-12-31 | $1.02M | 209.62% |
| 2017-12-31 | $328.53K | -44.53% |
| 2016-12-31 | $592.30K | 290.86% |
| 2015-12-31 | $151.54K | 385.80% |
| 2014-12-31 | $31.19K | 103.76% |
| 2013-12-31 | $15.31K | -98.10% |
| 2012-12-31 | $806.74K | -40.83% |
| 2011-12-31 | $1.36M | - |
BioStem Technologies generated $47.48M in revenue during NA 2025, up -84.27% compared to the previous quarter, and up 1882.98% compared to the same period a year ago.
BioStem Technologies Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-06-30 | $7.90M | 28.75% |
| 2026-03-31 | $6.14M | -107.23% |
| 2025-12-31 | $-84.82M | -909.82% |
| 2025-09-30 | $10.47M | -78.75% |
| 2025-06-30 | $49.30M | -32.03% |
| 2025-03-31 | $72.53M | -29.50% |
| 2024-12-31 | $102.87M | 24.61% |
| 2024-09-30 | $82.56M | 10.83% |
| 2024-06-30 | $74.49M | 77.77% |
| 2024-03-31 | $41.90M | 266.24% |
| 2023-12-31 | $11.44M | 217.91% |
| 2023-09-30 | $3.60M | 236.87% |
| 2023-06-30 | $1.07M | 85.45% |
| 2023-03-31 | $576.10K | -27.36% |
| 2022-12-31 | $793.09K | -30.78% |
| 2022-09-30 | $1.15M | -46.90% |
| 2022-06-30 | $2.16M | -22.34% |
| 2022-03-31 | $2.78M | 127.93% |
| 2021-12-31 | $1.22M | -7.16% |
| 2021-09-30 | $1.31M | 41.76% |
| 2021-06-30 | $926.31K | -2.75% |
| 2021-03-31 | $952.51K | -8.22% |
| 2020-12-31 | $1.04M | 121.94% |
| 2020-09-30 | $467.62K | 95.80% |
| 2020-06-30 | $238.83K | -69.28% |
| 2020-03-31 | $777.37K | 16.65% |
| 2019-12-31 | $666.39K | -7.80% |
| 2019-09-30 | $722.77K | 2.03% |
| 2019-06-30 | $708.37K | 32.96% |
| 2019-03-31 | $532.78K | -1.53% |
| 2018-12-31 | $541.07K | 43.56% |
| 2018-09-30 | $376.89K | 967.22% |
| 2018-06-30 | $35.31K | -44.75% |
| 2018-03-31 | $63.92K | 9.22% |
| 2017-12-31 | $58.53K | 5.86% |
| 2017-09-30 | $55.28K | -34.71% |
| 2017-06-30 | $84.67K | -26.19% |
| 2017-03-31 | $114.72K | 32.70% |
| 2016-12-31 | $86.45K | -58.46% |
| 2016-09-30 | $208.09K | -2.76% |
| 2016-06-30 | $214.00K | 43.53% |
| 2016-03-31 | $149.09K | -1.61% |
| 2015-12-31 | $151.54K | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | -100.00% |
| 2014-12-31 | $31.19K | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | -100.00% |
| 2013-09-30 | $15.31K | 100.00% |
| 2013-03-31 | - | - |
BioStem Technologies generated $7.90M in revenue during Q2 2026, up 28.75% compared to the previous quarter, and up 10.89% compared to the same period a year ago.
BioStem Technologies Revenue Breakdown
BioStem Technologies Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Jun 26 |
|---|---|
| Hospital | $6.71M |
| Other | $88.56K |
Latest
BioStem Technologies's latest quarterly revenue breakdown by segment (product or service), as of Jun 26: Hospital (98.70%), and Other (1.30%).